Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2025-12-24 @ 9:10 PM
NCT ID:
NCT07287904
Eligibility Criteria:
Inclusion Criteria:
1. Age 18-80 years, undergoing radical surgery for lung cancer (R0 resection);
2. Postoperative pathological stage IB-IIIA, pathology confirmed as adenocarcinoma;
3. EGFR gene testing positive, EGFR 19del/L858R mutation;
4. Receiving postoperative EGFR-TKI targeted adjuvant therapy;
5. Complete and clear preoperative imaging data, genetic testing report, and pathology report available.
Exclusion Criteria:
1. Patients negative for EGFR;
2. Incomplete surgical resection (R1, R2);
3. Did not receive EGFR-TKI targeted therapy after surgery;
4. Recurrent or advanced stage patients;
5. Incomplete preoperative or postoperative data;
6. Patients who died within 30 days post-surgery.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07287904
Study Brief:
Protocol Section:
NCT07287904